NFKB1 and inflammatory bowel disease: Supporting arguments for this hypothesis can be found in Papoutsopoulou et al. (2019), where the authors observed that inducing the NF-κB pathway in macrophages displayed sufficient variability to enable division of inflammatory bowel disease (IBD) patients into different clusters.